Literature DB >> 18334490

The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup.

Olivier Clermont1, Marie Lavollay, Sophie Vimont, Catherine Deschamps, Christiane Forestier, Catherine Branger, Erick Denamur, Guillaume Arlet.   

Abstract

OBJECTIVES: A clone of CTX-M-15-producing Escherichia coli has recently been reported to be spreading through Europe and Africa. The aim of this work was to thoroughly characterize this clone.
MATERIALS AND METHODS: Representative isolates of this clone were subjected to multilocus sequence typing, O typing, virulence gene detection, adhesion assay on human cells, biofilm production assay and mouse lethality assay.
RESULTS: The clone: (i) belongs to a unique B2 phylogenetic subgroup encompassing the pyelonephritogenic diffusely adhering EC7372 strain; (ii) exhibits a specific O25b molecular subtype; (iii) is identical to the E. coli clone O25:H4-ST131 producing CTX-M-15; (iv) produces biofilm; and (v) is highly virulent in mice despite lacking classical extraintestinal pathogenicity islands (except for high pathogenicity island) and the afa/dra gene.
CONCLUSIONS: The CTX-M-15-producing E. coli diffusing clone is associated with a high level of antibiotic resistance and with high virulence, showing that, under certain selective pressures, the previously observed trade-off between resistance and virulence may not apply.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334490     DOI: 10.1093/jac/dkn084

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  98 in total

1.  The Arginine Deiminase Operon Is Responsible for a Fitness Trade-Off in Extended-Spectrum-β-Lactamase-Producing Strains of Escherichia coli.

Authors:  Typhaine Billard-Pomares; Olivier Clermont; Miguel Castellanos; Fatma Magdoud; Guilhem Royer; Bénédicte Condamine; Stéphanie Fouteau; Valérie Barbe; David Roche; Stéphane Cruveiller; Claudine Médigue; Dominique Pognard; Jeremy Glodt; Sara Dion; Odile Rigal; Bertrand Picard; Erick Denamur; Catherine Branger
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia.

Authors:  R Ben Sallem; K Ben Slama; V Estepa; A Jouini; H Gharsa; N Klibi; Y Sáenz; F Ruiz-Larrea; A Boudabous; C Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-08       Impact factor: 3.267

3.  Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype.

Authors:  James R Johnson; Stephen B Porter; George Zhanel; Michael A Kuskowski; Erick Denamur
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

4.  Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.

Authors:  Constança Pomba; Joana Diniz da Fonseca; Bruno Coelho Baptista; José Duarte Correia; Luis Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

5.  High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.

Authors:  Véronique Duval; Ibrahim Maiga; Aminata Maiga; Thomas Guillard; Lucien Brasme; Dominique Forte; Janick Madoux; Véronique Vernet-Garnier; Christophe De Champs
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

6.  Feeding the probiotic Enterococcus faecium strain NCIMB 10415 to piglets specifically reduces the number of Escherichia coli pathotypes that adhere to the gut mucosa.

Authors:  Carmen Bednorz; Sebastian Guenther; Kathrin Oelgeschläger; Bianca Kinnemann; Robert Pieper; Susanne Hartmann; Karsten Tedin; Torsten Semmler; Konrad Neumann; Peter Schierack; Astrid Bethe; Lothar H Wieler
Journal:  Appl Environ Microbiol       Date:  2013-10-11       Impact factor: 4.792

7.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

8.  First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.

Authors:  Mohammad Hasan Namaei; Masoud Yousefi; Masoud Ziaee; Alireza Salehabadi; Malaknaz Ghannadkafi; Elham Amini; Parvin Askari
Journal:  Microb Drug Resist       Date:  2017-02-16       Impact factor: 3.431

9.  Extraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli Contamination of 56 Public Restrooms in the Greater Minneapolis-St. Paul Metropolitan Area.

Authors:  Muhanad Mohamed; Kris Owens; Abby Gajewski; Connie Clabots; Brian Johnston; Paul Thuras; Michael A Kuskowski; James R Johnson
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

10.  Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans.

Authors:  David Skurnik; Olivier Clermont; Thomas Guillard; Adrien Launay; Olga Danilchanka; Stéphanie Pons; Laure Diancourt; François Lebreton; Kristina Kadlec; Damien Roux; Deming Jiang; Sara Dion; Hugues Aschard; Maurice Denamur; Colette Cywes-Bentley; Stefan Schwarz; Olivier Tenaillon; Antoine Andremont; Bertrand Picard; John Mekalanos; Sylvain Brisse; Erick Denamur
Journal:  Mol Biol Evol       Date:  2015-11-26       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.